Bluesky Facebook Reddit Email

New Three Year Follow-up Data Of Novantrone In Multiple Sclerosis

Patients with secondary progressive multiple sclerosis treated with Novantrone experienced a sustained reduction in their number of attacks and delay in disability progression compared to those treated with placebo. The treatment resulted in generally manageable side effects and a smaller number of relapses in the third year.

Apple AirPods Pro (2nd Generation, USB-C)

Apple AirPods Pro (2nd Generation, USB-C) provide clear calls and strong noise reduction for interviews, conferences, and noisy field environments.

Immunex's TRAIL Molecule Shows Potential As Anti-Tumor Agent

A preclinical study published in Nature Medicine demonstrated that Immunex's TRAIL molecule suppresses tumor growth and induces complete remission in a high proportion of treated mice. The study shows promise for the treatment of various cancers, with the potential for minimal toxicity.

Penn Physicians Develop Clinical Guidelines For Herbal Therapies

Penn physicians developed clinical guidelines for herbal therapies, emphasizing the importance of understanding herbal agents' properties and potential risks. The guidelines caution against using certain herbal products, especially those with toxic effects, and recommend discussing risks and benefits with patients.